B-RAF with PLX4032

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
==B-RAF with PLX4032==
==B-RAF with PLX4032==
-
PLX4032 is a newly synthesized drug that is being used to treat malignant melanonma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.
+
PLX4032 is a newly synthesized drug that is being used to treat malignant melanoma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.

Revision as of 17:34, 30 September 2010

B-RAF with PLX4032

PLX4032 is a newly synthesized drug that is being used to treat malignant melanoma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.








testcaption

Drag the structure with the mouse to rotate

testcaption

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

J.D. Woodruff, Jens Hemmingsen, Michal Harel

Retrieved from "http://52.214.119.220/wiki/index.php/B-RAF_with_PLX4032"
Personal tools